Results 271 to 280 of about 2,600,985 (388)

A CASE OF THORACO-ABDOMINAL PENETRATING INJURIES MANAGED BY DAMAGE CONTROL

, 2006
Yoshihiro Moriwaki, Hiroshi Toyoda, Takayuki Kosuge, Mitsugi Sugiyama   +3 more
openalex   +2 more sources

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Isolated mesocolon injury and sigmoid colon necrosis secondary to abdominal blunt trauma. [PDF]

Trauma Case Rep
Ben Ismail I, Tounsi MK, Sghaier M, Boujemaa M, Zenaidi H, Zoghlami A.   +5 more
europepmc   +1 more source

Dapagliflozin alleviates high‐fat‐induced obesity cardiomyopathy by inhibiting ferroptosis

ESC Heart Failure, Volume 12, Issue 2, Page 1358-1373, April 2025.
Abstract Aim: Dapagliflozin (Dapa) is a novel hypoglycaemic agent with multiple cardiovascular protective effects, and it is widely used in treatment of heart failure patients, but whether it can improve obese phenotype of heart failure and its mechanism is still unclear.
Di Chen, Jiahao Shi, Yue Wu, Lizhu Miao, Zilin Wang, Yixuan Wang, Siwei Xu, Yu Lou   +7 more
wiley   +1 more source

Compression of the anterior abdominal wall resulting in colonic perforation in the absence of external injury: A rarely documented case. [PDF]

SAGE Open Med Case Rep
Upadhyay S, Upadhyay R, Gandhi A, Datta A, Vadaliya A, Barot R.   +5 more
europepmc   +1 more source

Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence

ESC Heart Failure, EarlyView.
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta, Manuel Garofalo, Samuele Salvi, Matteo Orlandi, Gianluca Marcaccini, Pietro Susini, Luca Checchi, Alberto Palazzuoli, Carlo Di Mario, Maurizio Pieroni, Matteo Beltrami   +10 more
wiley   +1 more source

Hepatic rupture as a life-threatening emergency and rare complication of CPR with the CORPULS device. [PDF]

J Surg Case Rep
Marín-Cuartas T, Pönitz S, Scholz S, Ritz JP, Sporn J, Protzel J.   +5 more
europepmc   +1 more source

EVALUATION OF ABDOMINAL BULLET INJURIES IN BASRAH GENERAL HOSPITAL (A PROSPECTIVE STUDY)

, 2006
Mazin A Abdellah, Mazin H Al-Hawaz, Jabar K Jassim   +2 more
openalex   +1 more source

Pathomechanismus in Septic Shock [PDF]

, 1986
Duswald, Karl-Heimo, Eitel, F., Fritz, Hans, Inthorn, D., Jochum, Marianne, Schweiberer, L.   +5 more
core  

Multi‐microRNA diagnostic panel for heart failure with preserved ejection fraction in preclinical and clinical settings

ESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex syndrome accounting for half of heart failure cases. Although natriuretic peptides are the most accepted and extensively used biomarkers for heart failure, their diagnostic accuracy for HFpEF remains debatable.
Reza Parvan, Natale Rolim, Andreas B. Gevaert, Alessandro Cataliotti, Emeline M. van Craenenbroeck, Volker Adams, Ulrik Wisløff, Gustavo Jose Justo Silva, on behalf of the OptimEx Study Group   +8 more
wiley   +1 more source